Imperagen
Closed-loop, AI-guided enzyme engineering
Manchester, United Kingdom · Founded 2021 · $6.5M raised
- Headquarters
- Manchester
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- imperagen.com
- Total Funding
- $6.5M
- Last Round
- $6.5M Venture RoundMay 2026
- Rounds
- 1
About
Imperagen is a Manchester-based techbio company founded in November 2021 by researchers from the University of Manchester's Institute of Biotechnology. Its closed-loop platform combines quantum physics-based AI simulation with high-throughput automated lab testing to engineer improved enzymes faster and at lower cost. The company closed a £5 million seed round in May 2026.
Summary
Imperagen is a Biotech company based in Manchester, United Kingdom, founded in 2021. It has raised $6.5M in total across 1 round, most recently a $6.5M Venture Round round in May 2026.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imperagen"><img src="https://indexed.vc/api/badge/company/imperagen" alt="Imperagen on Indexed.vc" width="260" height="76" /></a>